Modulight Oyj

Equities

MODU

FI4000511506

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki Other stock markets 11:15:18 2024-04-26 am EDT			5-day change	1st Jan Change
0.826 ^EUR	-8.93%		-9.23%	-29.64%

Feb. 24	Modulight Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
Feb. 23	Transcript : Modulight Oyj, 2023 Earnings Call, Feb 23, 2024

Modulight Oyj has completed an IPO in the amount of €79.008598 million.

September 29, 2021 at 12:00 am EDT

Modulight Oyj has completed an IPO in the amount of €79.008598 million. Security Name: Shares Security Type: Common Stock Securities Offered: 12,173,898 PriceRange: €6.49 Transaction Features: Regulation S

Latest news about Modulight Oyj

Modulight Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 23	CI
Transcript : Modulight Oyj, 2023 Earnings Call, Feb 23, 2024	Feb. 23
Finland's Modulight Marks UK, Irish Expansion with Laser 2000 UK Sales Partnership	Feb. 09	MT
Modulight Forges Strategic Partnership with Laser 2000 (Uk) Limited for Market Expansion in the Uk and Ireland	Feb. 09	CI
Transcript : Modulight Oyj, Q3 2023 Earnings Call, Oct 20, 2023	23-10-20
Certain Shares of Modulight Oyj are subject to a Lock-Up Agreement Ending on 21-SEP-2023.	23-09-20	CI
Pioneering Study Confirms Benefits of Modulight Oyj Technology and Photoimmunotherapy for Ovarian Cancer	23-09-06	CI
Modulight Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Transcript : Modulight Oyj, Q2 2023 Earnings Call, Aug 18, 2023	23-08-18
Modulight Corporation Announces Board and Committee Appointments	23-05-02	CI
Transcript : Modulight Oyj, Q1 2023 Earnings Call, Apr 28, 2023	23-04-28
Transcript : Modulight Oyj, 2022 Earnings Call, Feb 23, 2023	23-02-23
Bausch + Lomb, Modulight Get FDA OK for ML6710i, Visudyne Photodynamic Laser Treatment	23-02-01	DJ
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with B+L'sVisudyne	23-02-01	MT
Bausch + Lomb Brief: Bausch + Lomb and Modulight Announcing FDA Approval of ML6710i Photodynamic Laser for Use with BLCO's VISUDYNE (Verteporfin for Injection)	23-02-01	MT
Modulight Corp. Expands Sales in Europe Through A Distribution Partnership with Laser 2000	23-01-26	CI
FDA Approves Modulight Corp.'s ML6710i Laser Device for AMD Treatment	23-01-23	CI
Transcript : Modulight Oyj, Q3 2022 Earnings Call, Oct 20, 2022	22-10-20
Modulight Oyj(HLSE:MODU) dropped from S&P Global BMI Index	22-09-19	CI
Modulight Receives a $3.9 Million Purchase Order	22-04-20	CI
Modulight Ojy Receives Purchase Order for Pilot Project	22-03-31	CI
Modulight Oyj(HLSE:MODU) added to S&P Global BMI Index	22-03-21	CI
Modulight Corporation Announces Composition of the Board of Directors	21-09-30	CI
Modulight Oyj has completed an IPO in the amount of €79.008598 million.	21-09-29	CI
Modulight Oyj has filed an IPO in the amount of €60 million.	21-09-09	CI

Chart Modulight Oyj

Duration

Period

More charts

Company Profile

Modulight Oyj is a Finland-based technology company that designs, markets and manufactures laser products, including semiconductors, laser modules, complete cloud connected laser systems and related software and analytics services for demanding medical technology and technology companies and target markets around the world. Modulight provides biomedical lasers for medical applications, including oncology, ophthalmology and genetics, as well as other diagnostics for medical and biomedical segments. Additionally, the Company offers customized biomedical laser solutions, including wavelength, optical power and laser output beam engineering enabled by its own fabrication plant and semiconductor process. Modulight Oyj is the Group's Parent Company. The Companyâs subsidiaries include Modulight China Export A Oy, Leaptek Photonics Oy, and Modulight USA Inc.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-01 - Annual General Meeting

More about the company